Keenova Therapeutics plc
MNKTQDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567892
Keenova Therapeutics plc was delisted in 2023; its insiders filed their last Form 4 on Jul 23, 2026; 36 institutions reported holding it in 13F filings for Q2 2023, worth $12.4M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 36
- Q2 2023, −9 vs. previous quarter
- 13F value
- $12.4M
- Reported value at the end of Q2 2023
- Superinvestors holding
- 0
- At the end of Q2 2023
Superinvestors holding MNKTQ, Q2 2023
No superinvestor reported holding MNKTQ at the end of Q2 2023.
Latest insider trades
Open-market purchases and sales by Keenova Therapeutics plc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2026 (view filing)8:59 PM ET | May 19-20 | 2 days | Mule Edward A and 2 others10% Owner | PPurchase | +397.5K | $90.50 | +$36.0M | +7.1%6.04M after | 2 lots |
| Apr 17, 2026 (view filing)5:23 PM ET | Apr 15-17 | 2 days | Mule Edward A and 2 others10% Owner | PPurchase | +685.0K | $89.70 | +$61.4M | +13.8%5.64M after | 2 lots |
| Jan 9, 2026 (view filing)5:26 PM ET | Jan 7 | 2 days | Mule Edward A and 2 others10% Owner | PPurchase | +250.0K | $92.25 | +$23.1M | +5.3%4.95M after | |
| Dec 10, 2025 (view filing)6:14 PM ET | Dec 8 | 2 days | Mule Edward A and 2 others10% Owner | PPurchase | +131.0K | $88.75 | +$11.6M | +2.9%4.70M after | |
| Nov 19, 2025 (view filing)6:39 PM ET | Nov 17-19 | 2 days | Mule Edward A and 2 others10% Owner | PPurchase | +68.0K | $88.88 | +$6.04M | +1.5%4.57M after | 2 lots |
| Nov 12, 2025 (view filing)8:16 PM ET | Nov 10 | 2 days | Mule Edward A and 2 others10% Owner | PPurchase | +290.0K | $93.75 | +$27.2M | +6.9%4.50M after | |
| Aug 6, 2025 (view filing)7:45 PM ET | Aug 4-6 | 2 days | Goldentree Asset Management LP and 2 others10% Owner | PPurchase | +36.7K | $88.21 | +$3.24M | +0.5%7.95M after | 2 lots |
| Aug 4, 2025 (view filing)4:45 PM ET | Aug 1 | 3 days | Goldentree Asset Management LP and 2 others10% Owner | PPurchase | +50.0K | $86.50 | +$4.33M | +0.6%7.91M after | |
| Jul 10, 2024 (view filing)4:30 PM ET | Jul 8 | 2 days | Goldentree Asset Management LP and 2 others10% Owner | PPurchase | +13.3K | $54.50 | +$724.9K | +0.4%3.33M after | |
| Jun 18, 2024 (view filing)4:30 PM ET | Jun 14 | 4 days | Goldentree Asset Management LP and 2 others10% Owner | PPurchase | +275.0K | $52.75 | +$14.5M | +9.0%3.31M after |
Top 10 13F holders, Q2 2023
The largest institutional positions in Keenova Therapeutics plc at the end of Q2 2023; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bracebridge Capital, LLC | 2,033,257 | $2.40M | 1.91% | 00.0% | Unchanged |
| Alta Fundamental Advisers LLC | 1,947,093 | $2.30M | 1.26% | +1,215,000+166.0% | Added |
| JPMorgan Chase & Co | 1,316,260 | $1.55M | 0.00% | −365,378−21.7% | Reduced |
| Hudson Bay Capital Management LP | 1,041,560 | $1.23M | 0.01% | −100,000−8.8% | Reduced |
| Continental General Insurance Co | 880,822 | $1.04M | 0.37% | +781,154+783.8% | Added |
| Sculptor Capital LP | 694,649 | $819.7K | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 644,153 | $760.1K | 0.00% | 00.0% | Unchanged |
| Two Seas Capital LP | 585,602 | $691.0K | 0.15% | +568,346+3,293.6% | Added |
| BlackRock Inc. | 203,658 | $240.3K | 0.00% | +11,351+5.9% | Added |
| Bank of America Corp | 156,282 | $184.4K | 0.00% | −600.0% | Reduced |